Several deregulated growth factor circuits have been described for Ewing sarcoma cells in the literature such as signaling through the insulin-like growth factor I receptor [18], by human gastrin-releasing peptide [19] and basic fibroblast growth factor [20], as well as platelet derived growth factor[21,22]. This evidence concerns the gene IGF1R and Ewing sarcoma.